Dependence of Macrophage Phagocytic Efficacy on Antibody Concentration
- 1 April 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (4), 1904-1915
- https://doi.org/10.1128/iai.01258-06
Abstract
Macrophages ingest the fungus Cryptococcus neoformans only in the presence of opsonins, and this provides a remarkably clean system for the detailed analysis of phagocytosis. This system is also unusual in that antibody-mediated phagocytosis involves ingestion through both Fc and complement receptors in the absence of complement. Mathematical modeling was used to analyze and explain the experimental data that the macrophage phagocytic index increased with increasing doses of antibody despite saturating concentrations and declined at high concentrations. A model was developed that explains the increase in phagocytic index with increasing antibody doses, differentiates among the contributions from Fc and complement receptors, and provides a tool for estimating antibody concentrations that optimize efficacy of phagocytosis. Experimental results and model calculations revealed that blocking of Fc receptors by excess antibody caused a reduction in phagocytic index but increased phagocytosis through complement receptors rapidly compensated for this effect. At high antibody concentrations, a further reduction in phagocytic index was caused by interference with complement receptor ingestion as a consequence of saturation of the fungal capsule. The ability of our model to predict the antibody dose dependence of the macrophage phagocytic efficacy for C. neoformans strongly suggest that the major variables that determine the efficacy of this process have been identified. The model predicts that the affinity constant of the opsonic antibody for the Fc receptor and the association-dissociation constant of antibody from the microbial antigen are critical parameters determining the efficacy of phagocytosis.Keywords
This publication has 18 references indexed in Scilit:
- Interaction of Radiolabeled Antibodies with Fungal Cells and Components of the Immune System In Vitro and during Radioimmunotherapy for Experimental Fungal InfectionThe Journal of Infectious Diseases, 2006
- Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannanMolecular Immunology, 2006
- Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal MeningitisAntimicrobial Agents and Chemotherapy, 2005
- The methodology for determining the efficacy of antibody-mediated immunityJournal of Immunological Methods, 2004
- CryptococcosisInfectious Disease Clinics of North America, 2002
- CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformansImmunity, 2002
- Replication ofCryptococcus neoformansin macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasmProceedings of the National Academy of Sciences of the United States of America, 2002
- J774 Murine Macrophage-like Cell Interactions with Cryptococcus neoformans in the Presence and Absence of OpsoninsThe Journal of Infectious Diseases, 1996
- Development of mathematical models for an in vitro-phagocytosis test systemZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1987
- Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis.The Journal of cell biology, 1983